Help us: Donate
Follow us on:
×

Menu

Back

Panel Discussion of the Valley of Death at EARD2020

The Valley of Death at Ending Age-Related Diseases 2020The Valley of Death at Ending Age-Related Diseases 2020
 

At this panel from Ending Age-Related Diseases 2020, Javier Noris of Lifespan.io talks with Patrick Burgermeister of Kizoo Ventures, Reason of Repair Biotechnologies, Sergio Ruiz of Methuselah Labs, and Ronjon Nag of Institute R42 about the valley of death in biotech investment. Early-stage research is funded by universities and governments, and companies are funded by investors, but it is difficult for researchers to bring their findings to the level at which investors would be interested, and being unable to cross this valley of death is a significant hindrance for the development of rejuvenation biotechnology. Being able to reliably overcome this would be a major benefit for the development of therapies that directly target the root causes of aging.

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

No Comments
Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.